Inflectra

DRUG2 trials

Sponsors

Pfizer

Conditions

Arthritis, RheumatoidCrohn's Disease (CD)Inflammatory Bowel Disease (IBD)Ulcerative Colitis (UC)

Unknown Phase

Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease

CompletedNCT03801928

PfizerCrohn's Disease (CD), Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC)

Start: 2018-02-23End: 2020-02-07Updated: 2021-03-02

This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis Registry

CompletedNCT05375942

PfizerArthritis, Rheumatoid

Start: 2022-11-11End: 2022-11-11Updated: 2024-04-12

Related Papers

Impact of Infliximab-dyyb (Infliximab Biosimilar) on Clinical and Patient-Reported Outcomes: 1-Year Follow-up Results from an Observational Real-World Study Among Patients with Inflammatory Bowel Disease in the US and Canada (the ONWARD Study).

2022-03-163 citations